Literature DB >> 11382783

Interaction of two structurally distinct sequence types with the clathrin terminal domain beta-propeller.

M T Drake1, L M Traub.   

Abstract

The amino-terminal domain of the clathrin heavy chain, which folds into a seven-bladed beta-propeller, binds directly to several endocytic proteins via short sequences based on the consensus residues LLDLD. In addition to a single LLDLD-based, type I clathrin-binding sequence, both amphiphysin and epsin contain a second, distinct sequence that is also capable of binding to clathrin directly. Here, we analyzed these sequences, which we term type II sequences, and show that the (257)LMDLA sequence in rat epsin 1 appears to be a weak clathrin-binding variant of the sequence (417)PWDLW originally found in human amphiphysin II. The structural features of the type II sequence required for association with clathrin are distinct from the LLDLD-based sequence. In the central segment of amphiphysin, the type I and type II sequences cooperate to effect optimal clathrin binding and the formation of sedimentable assemblies. Together, the data provide evidence for two interaction surfaces upon certain endocytic accessory proteins that could cooperate with other coat components to enhance clathrin bud formation at the cell surface.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11382783     DOI: 10.1074/jbc.M104226200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Functional analysis of interaction sites on the N-terminal domain of clathrin heavy chain.

Authors:  Anna K Willox; Stephen J Royle
Journal:  Traffic       Date:  2011-10-20       Impact factor: 6.215

2.  Two WXXF-based motifs in NECAPs define the specificity of accessory protein binding to AP-1 and AP-2.

Authors:  Brigitte Ritter; Alexei Yu Denisov; Jacynthe Philie; Christophe Deprez; Elaine C Tung; Kalle Gehring; Peter S McPherson
Journal:  EMBO J       Date:  2004-09-09       Impact factor: 11.598

3.  Reconstitution of clathrin-coated bud and vesicle formation with minimal components.

Authors:  Philip N Dannhauser; Ernst J Ungewickell
Journal:  Nat Cell Biol       Date:  2012-04-22       Impact factor: 28.824

4.  Dynamic interactions between clathrin and locally structured elements in a disordered protein mediate clathrin lattice assembly.

Authors:  Yue Zhuo; Udayar Ilangovan; Virgil Schirf; Borries Demeler; Rui Sousa; Andrew P Hinck; Eileen M Lafer
Journal:  J Mol Biol       Date:  2010-09-25       Impact factor: 5.469

5.  The gamma/sigma1 and alpha/sigma2 hemicomplexes of clathrin adaptors AP-1 and AP-2 harbor the dileucine recognition site.

Authors:  Balraj Doray; Intaek Lee; Jane Knisely; Guojun Bu; Stuart Kornfeld
Journal:  Mol Biol Cell       Date:  2007-03-14       Impact factor: 4.138

Review 6.  Cargo recognition in clathrin-mediated endocytosis.

Authors:  Linton M Traub; Juan S Bonifacino
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-11-01       Impact factor: 10.005

7.  Regulation of clathrin adaptor function in endocytosis: novel role for the SAM domain.

Authors:  Santiago M Di Pietro; Duilio Cascio; Daniel Feliciano; James U Bowie; Gregory S Payne
Journal:  EMBO J       Date:  2010-02-11       Impact factor: 11.598

8.  Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor.

Authors:  Sanjay K Mishra; Peter A Keyel; Matthew J Hawryluk; Nicole R Agostinelli; Simon C Watkins; Linton M Traub
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

9.  Mutations in the clathrin-assembly gene Picalm are responsible for the hematopoietic and iron metabolism abnormalities in fit1 mice.

Authors:  Mitchell L Klebig; Melissa D Wall; Mark D Potter; Erica L Rowe; Donald A Carpenter; Eugene M Rinchik
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 11.205

10.  Participation of Tom1L1 in EGF-stimulated endocytosis of EGF receptor.

Authors:  Ning Sheng Liu; Li Shen Loo; Eva Loh; Li-Fong Seet; Wanjin Hong
Journal:  EMBO J       Date:  2009-10-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.